Diebold Nixdorf, Incorporated (DBD) Income Statement
DBD 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsDBD revenue and net income
Where DBD's revenue goes
2025Each bar shows an amount and its share of revenue. DBD kept 2.5% of revenue as net income.
DBD profit margins
DBD growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +1.5% | +3.2% | −0.5% | +4.6% |
| Gross profit | +9.1% | +9.8% | −0.6% | +4.3% |
| Operating income | +83.7% | — | +69.4% | +9.6% |
| Net income | — | — | — | +2.1% |
| EPS (diluted) | +19.3% | — | +44.8% | +10.0% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DBD quarterly EPS vs estimates
Diebold Nixdorf beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: October 28, 2026 (estimate $1.38).
DBD income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.81B | $3.75B | $3.76B | $3.46B | $3.91B | $3.90B | $4.41B | $4.58B | $4.61B | $3.32B |
| Cost of revenue | $2.80B | $2.83B | $2.88B | $2.70B | $2.86B | $2.87B | $3.33B | $3.69B | $3.58B | $2.57B |
| Gross profit | $1.00B | $920.0M | $876.2M | $757.3M | $1.04B | $1.03B | $1.08B | $890.9M | $1.03B | $747.2M |
| Research & development | $83.8M | $93.6M | $110.9M | $120.7M | $126.3M | $133.4M | $144.1M | $157.4M | $156.6M | $105.1M |
| Sales, general & admin | $632.5M | $643.6M | — | $741.6M | $775.6M | $858.6M | $908.8M | — | — | — |
| Total operating expenses | $668.8M | $737.9M | $789.3M | $969.0M | $906.3M | $1.01B | $841.4M | $1.04B | $893.6M | $686.7M |
| Operating income | $334.6M | $182.1M | $86.9M | −$211.7M | $137.1M | $24.0M | $235.0M | −$362.9M | $135.4M | $60.5M |
| Interest income | $8.9M | $12.3M | — | $10.0M | $6.1M | $6.8M | $9.3M | — | — | — |
| Interest expense | $85.7M | $155.3M | $246.2M | $199.2M | $195.3M | $273.4M | $202.9M | $154.9M | $117.3M | $101.4M |
| Income before taxes | $121.6M | $49.8M | $1.45B | −$436.4M | −$50.4M | −$268.8M | −$227.9M | −$515.6M | −$191.9M | −$238.3M |
| Income taxes | $24.1M | $64.3M | $75.7M | $149.2M | $27.7M | −$1.0M | $116.7M | $37.2M | $28.3M | −$67.6M |
| Net income | $94.6M | −$16.5M | $1.38B | −$581.4M | −$78.8M | −$269.1M | −$341.3M | −$568.7M | −$241.5M | −$178.0M |
| EBITDA | $334.8M | $334.9M | $284.9M | −$113.4M | $293.7M | $177.7M | $193.3M | −$81.1M | $177.6M | −$7.0M |
| EPS (diluted) | $4.83 | $4.05 | −$0.31 | −$0.56 | $0.79 | $0.76 | −$0.16 | −$1.02 | $1.14 | $1.04 |
| Gross margin | 26.4% | 24.5% | 23.3% | 21.9% | 26.7% | 26.5% | 24.4% | 19.5% | 22.3% | 22.5% |
| Operating margin | 8.8% | 4.9% | 2.3% | −6.1% | 3.5% | 0.6% | 5.3% | −7.9% | 2.9% | 1.8% |
| Net margin | 2.5% | −0.4% | 36.6% | −16.8% | −2.0% | −6.9% | −7.7% | −12.4% | −5.2% | −5.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $930.8M | $891.8M | $1.10B | $945.2M | $915.2M | $841.1M | $988.9M | $927.1M | $939.7M | $895.4M | $1.04B | $943.4M |
| Cost of revenue | $691.2M | $666.6M | $804.5M | $697.3M | $672.5M | $627.9M | $752.5M | $690.5M | $696.5M | $686.8M | $812.0M | $731.3M |
| Gross profit | $239.6M | $225.2M | $299.7M | $247.9M | $242.7M | $213.2M | $236.4M | $236.6M | $243.2M | $208.6M | $224.8M | $212.1M |
| Research & development | $20.5M | $22.1M | $21.0M | $20.3M | $22.2M | $20.3M | $25.6M | $23.4M | $22.1M | $24.2M | $23.4M | $22.5M |
| Sales, general & admin | $162.3M | $145.3M | $175.6M | $150.9M | $147.9M | $145.0M | $165.2M | $164.6M | $152.2M | $161.6M | — | — |
| Total operating expenses | $182.2M | $167.4M | $172.1M | $174.1M | $170.1M | $165.3M | $195.2M | $190.2M | $172.5M | $184.8M | $169.3M | $174.7M |
| Operating income | $57.4M | $57.8M | $127.6M | $73.8M | $72.6M | $47.9M | $41.2M | $46.4M | $70.7M | $23.8M | $55.5M | $37.4M |
| Interest income | $2.1M | $2.9M | $2.8M | $2.1M | $2.5M | $1.5M | $2.2M | $2.9M | $3.0M | $4.2M | — | — |
| Interest expense | $24.1M | $23.3M | $20.6M | $21.8M | $21.8M | $21.5M | $34.7M | $38.4M | $38.6M | $43.6M | $25.3M | $69.3M |
| Income before taxes | $36.3M | $11.2M | $62.4M | $51.3M | $17.5M | −$9.7M | $11.9M | $8.2M | $46.8M | −$17.1M | $24.4M | $2.22B |
| Income taxes | $19.2M | $5.7M | $11.9M | $9.6M | $4.8M | −$2.2M | $5.5M | $29.9M | $32.0M | −$3.1M | $1.5M | $80.9M |
| Net income | $15.5M | $5.0M | $49.6M | $41.1M | $12.2M | −$8.3M | $5.6M | −$22.4M | $14.9M | −$14.6M | $22.3M | $2.14B |
| EBITDA | $88.2M | $65.9M | $113.7M | $104.8M | $70.5M | $45.7M | $132.4M | $78.7M | $114.1M | $62.7M | $111.1M | $84.9M |
| EPS (diluted) | $1.10 | $0.67 | $2.75 | $1.39 | $0.60 | $0.09 | $0.99 | $0.70 | $1.16 | $1.20 | $3.02 | −$2.86 |
| Gross margin | 25.7% | 25.3% | 27.1% | 26.2% | 26.5% | 25.3% | 23.9% | 25.5% | 25.9% | 23.3% | 21.7% | 22.5% |
| Operating margin | 6.2% | 6.5% | 11.6% | 7.8% | 7.9% | 5.7% | 4.2% | 5.0% | 7.5% | 2.7% | 5.4% | 4.0% |
| Net margin | 1.7% | 0.6% | 4.5% | 4.3% | 1.3% | −1.0% | 0.6% | −2.4% | 1.6% | −1.6% | 2.2% | 227.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DBD's financial statements (latest annual report filed February 12, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DBD financial results
In fiscal year 2025 (ended December 31, 2025), Diebold Nixdorf reported revenue of $3.8 billion, up 1.5% from the year before. It had net income of $94.6 million, a net profit margin of 2.5%. Diluted earnings per share came to $4.83. Over five years revenue grew at an average rate of −0.5% a year.
See the DBD stock overview for the latest quote and news, or the DBD chart for price history and technical indicators.
DBD income statement FAQ
What is Diebold Nixdorf's annual revenue?
Diebold Nixdorf reported total revenue of $3.8 billion for fiscal year 2025, which ended on December 31, 2025. That was up 1.5% from $3.8 billion the previous year.
Is Diebold Nixdorf profitable?
Yes. Diebold Nixdorf reported net income of $94.6 million in fiscal 2025, a net profit margin of 2.5%; its operating margin was 8.8%.
What is Diebold Nixdorf's gross margin?
Diebold Nixdorf's gross margin was 26.4% in fiscal 2025: for every $100 of revenue, Diebold Nixdorf kept $26 after the direct cost of its products and services.
How much does Diebold Nixdorf spend on research and development?
Diebold Nixdorf spent $83.8 million on research and development in fiscal 2025, 2.2% of revenue.
How fast is Diebold Nixdorf growing?
Revenue grew −0.5% a year on average over the last five fiscal years, from $3.9 billion to $3.8 billion.
What are Diebold Nixdorf's earnings per share?
Diebold Nixdorf earned $4.83 per diluted share in fiscal 2025, compared with $4.05 a year earlier.
When will Diebold Nixdorf report its next earnings?
Diebold Nixdorf is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 before the market opens.
When does Diebold Nixdorf's fiscal year end?
Diebold Nixdorf's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 12, 2026.